Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
We thank the authors for their interest in our work.1–3 Their approach and results provide yet additional support to the adverse impact of warfarin on osteoarthritis outcomes, as compared with direct oral anticoagulants.
Data availability statement
Deidentified data were used for this work. These data are not publicly available. The IMRD dataset used in this work is a subscription-based dataset with a legal contract requiring data to remain onsite and analysed at Boston University Medical Center. We are therefore legally unable to make these data publicly available. We would be able to collaborate with potential external investigators to address research questions of interest if appropriate resources are provided. Investigators may contact IMRD for further information about obtaining data.
Patient consent for publication
Boston University Medical Campus Institutional Review Board (protocol H-32821).
Contributors PB was involved in drafting the response and critical revision. CP and TN were involved in critical revision.
Funding This work and CP were supported by NIH P30AR072571. TN was supported by NIH K24AR070892. Sponsors played no role in the conduct of the study or preparation of this manuscript.
Competing interests None declared.
Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.
Provenance and peer review Commissioned; internally peer reviewed.